12-53424398-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PS1_ModeratePM2PP5_Moderate
The NM_020547.3(AMHR2):c.160C>T(p.Arg54Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,622 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 1 hom. )
Consequence
AMHR2
NM_020547.3 missense
NM_020547.3 missense
Scores
5
9
5
Clinical Significance
Conservation
PhyloP100: 3.86
Genes affected
AMHR2 (HGNC:465): (anti-Mullerian hormone receptor type 2) This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PS1
Transcript NM_020547.3 (AMHR2) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in UniProt
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-53424398-C-T is Pathogenic according to our data. Variant chr12-53424398-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3366389.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMHR2 | NM_020547.3 | c.160C>T | p.Arg54Cys | missense_variant | 2/11 | ENST00000257863.9 | NP_065434.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMHR2 | ENST00000257863.9 | c.160C>T | p.Arg54Cys | missense_variant | 2/11 | 1 | NM_020547.3 | ENSP00000257863.3 | ||
AMHR2 | ENST00000379791.7 | c.160C>T | p.Arg54Cys | missense_variant | 2/9 | 1 | ENSP00000369117.3 | |||
AMHR2 | ENST00000550311.5 | c.160C>T | p.Arg54Cys | missense_variant | 2/11 | 1 | ENSP00000446661.1 | |||
AMHR2 | ENST00000553037.1 | n.121C>T | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000639 AC: 16AN: 250270Hom.: 1 AF XY: 0.0000960 AC XY: 13AN XY: 135432
GnomAD3 exomes
AF:
AC:
16
AN:
250270
Hom.:
AF XY:
AC XY:
13
AN XY:
135432
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461354Hom.: 1 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 726980
GnomAD4 exome
AF:
AC:
27
AN:
1461354
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
726980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74452
GnomAD4 genome
AF:
AC:
2
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
10
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Persistent Mullerian duct syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 08, 2024 | Variant summary: AMHR2 c.160C>T (p.Arg54Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 250270 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in AMHR2 causing Persistent Mullerian duct syndrome, allowing no conclusion about variant significance. c.160C>T has been reported in the literature in the compound heterozygous state in at least 2 individuals affected with Persistent Mullerian duct syndrome (example, Imbeaud_1996, Tian_2022), including at least 1 individual carrying a pathogenic variant in trans. These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. In vitro experiments showed this variant prevented binding of the ligand protein (encoded by AMH) and also eliminated the activation of a target gene by AMH, suggesting the activation pathway is disrupted by this variant (example, Belville_2009). The following publications have been ascertained in the context of this evaluation (PMID: 19457927, 8872466, 34810374). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;L;L
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Pathogenic
Sift
Uncertain
D;T;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Gain of catalytic residue at R59 (P = 9e-04);Gain of catalytic residue at R59 (P = 9e-04);Gain of catalytic residue at R59 (P = 9e-04);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at